# Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia

> **NCT05002699** · — · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 120 (estimated)

## Conditions studied

- Alzheimer Disease
- Dementia
- Cognitive Impairment
- Mild Cognitive Impairment

## Interventions

- **DIAGNOSTIC_TEST:** Alzheimer's disease CSF biomarkers

## Key facts

- **NCT ID:** NCT05002699
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2022-08
- **Final completion:** 2023-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-05-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05002699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05002699, "Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05002699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*